Table 4 Differential daily mean VAS score parameter estimates for pre-during and pre-post exposure reported pain scores between the VR and control groups for participants with pre-exposure substantial pain (Daily Pre-exposure Pain Scores of ≥ 40 mm)
| Â | VR | Control | Group Differential* VR vs Control, (95%CI) | ||||
|---|---|---|---|---|---|---|---|
Predictor | VAS Pre-exposure Mean (SE) | VAS Mean (SE) | VAS Change (SE) | VAS Pre-exposure Mean (SE) | VAS Mean (SE) | VAS Change (SE) | Group Differential* VR vs Control, (95%CI) |
Overall | |||||||
 Pre-during | 54.97 (1.84) | 43.10 (1.84) | -11.87 (0.72) | 57.27 (1.89) | 45.09 (1.89) | -12.18 (0.79) | 0.31 (-1.79, 2.45) |
 Pre-post | 54.97 (1.84) | 44.55 (1.84) | -10.42 (0.72) | 57.27 (1.89) | 42.96 (1.89) | -14.31 (0.79) | 3.89 (1.78, 6.21) |
CL/WN | |||||||
 Pre-during | 58.12 (2.29) | 44.07 (2.29) | -14.04 (1.42) | 55.92 (2.46) | 40.46 (2.46) | -15.46 (1.63) | 1.41 (-3.05, 5.66) |
 Pre-post | 58.12 (2.29) | 48.45 (2.29) | -9.67 (1.42) | 55.92 (2.46) | 43.53 (2.46) | -12.39 (1.63) | 2.73 (-1.74, 6.80) |
VMW | |||||||
 Pre-during | 54.57 (2.19) | 45.94 (2.19) | -8.64 (1.14) | 56.23 (2.29) | 45.24 (2.29) | -10.99 (1.25) | 2.35 (-1.04, 5.51) |
 Pre-post | 54.57 (2.19) | 44.68 (2.19) | -9.89 (1.14) | 56.23 (2.29) | 41.00 (2.29) | -15.23 (1.25) | 5.33 (1.80, 8.37) |
OB | |||||||
 Pre-during | 55.35 (2.44) | 40.80 (2.44) | -14.55 (1.35) | 58.41 (2.60) | 44.77 (2.61) | -13.64 (1.51) | -0.91 (-4.93, 3.12) |
 Pre-post | 55.35 (2.44) | 44.24 (2.44) | -11.11 (1.35) | 58.41 (2.60) | 43.35 (2.61) | -15.06 (1.51) | 3.95 (-0.35, 7.50) |
WF | |||||||
 Pre-during | 57.05 (2.23) | 46.93 (2.23) | -10.13 (1.33) | 58.70 (2.34) | 49.89 (2.34) | -8.81 (1.42) | -1.32 (-4.60, 2.38) |
 Pre-post | 57.05 (2.23) | 46.00 (2.23) | -11.05 (1.33) | 58.70 (2.34) | 44.38 (2.34) | -14.32 (1.43) | 3.27 (-0.34, 7.15) |